
Antibiotic prophylaxis with trimethoprim/sulfamethoxazole significantly reduces the risk of recurrence of urinary tract infection (UTI) in children with vesicoureteral reflux after UTI, but does not reduce the risk of renal scarring, according to a randomized, placebo-controlled trial.
